Literature DB >> 6932918

Assessment of tumour growth and of response to chemotherapy of human melanomas in athymic, nude mice.

O Fodstad, N Aass, A Pihl.   

Abstract

The growth of 6 different human melanomas xenografted into athymic mice was followed by measuring 2 vertical diameters twice weekly. The growth rate of the xenografts was expressed as the tumour doubling time, measured in the volume range 30-60 mm3. None of the xenografts increased their growth rate with increasing number of passages. The tumour lines, which were histologically very similar, showed individual, characteristic growth rates differing by a factor of 3. Evidence was obtained that resistance to cytostatic drugs in the patients is retained in the xenograft. Procedures for evaluating response to chemotherapy are discussed.

Entities:  

Mesh:

Year:  1980        PMID: 6932918      PMCID: PMC2149253     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  6 in total

1.  Chemotherapy of human colon cancer xenografts in athymic nude mice.

Authors:  R Osieka; D P Houchens; A Goldin; R K Johnson
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

Review 2.  DTIC (NSC-45388) in malignant melanoma: a perspective.

Authors:  R L Comis
Journal:  Cancer Treat Rep       Date:  1976-02

3.  Inhibitory effect of abrin and ricin on the growth of transplantable murine tumors and of abrin on human cancers in nude mice.

Authors:  O Fodstad; S Olsnes; A Pihl
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

Review 4.  The growth and therapeutic response of human tumours in immune deficient mice.

Authors:  G G Steel
Journal:  Bull Cancer       Date:  1978       Impact factor: 1.276

5.  The growth kinetics of xenografts of human colorectal tumours in immune deprived mice.

Authors:  R G Pickard; L M Cobb; G G Steel
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

6.  Variation in response of xenografts of colo-rectal carcinoma to chemotherapy.

Authors:  K Nowak; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

  6 in total
  9 in total

1.  Nude rat models for human tumor metastasis to CNS. Procedures for intracarotid delivery of cancer cells and drugs.

Authors:  A T Myklebust; A Helseth; K Breistøl; W A Hall; O Fodstad
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  The potential of the nude mouse xenograft model for the study of head and neck cancer.

Authors:  B J Braakhuis; G Sneeuwloper; G B Snow
Journal:  Arch Otorhinolaryngol       Date:  1984

3.  Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice.

Authors:  I Kjønniksen; P D Rye; O Fodstad
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

4.  Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.

Authors:  E Kjellén; J Wennerberg; R Pero
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

5.  Progressive growth of a human pleural mesothelioma xenografted to athymic rats and mice.

Authors:  C J Lindén; L Johansson
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

6.  Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice.

Authors:  S Aamdal; O Fodstad; J M Nesland; A Pihl
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

7.  Do cell lines in vitro reflect the properties of the tumours of origin? A study of lines derived from human melanoma xenografts.

Authors:  K M Tveit; A Pihl
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

8.  Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.

Authors:  K M Tveit; L Endresen; H E Rugstad; O Fodstad; A Pihl
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

9.  Chick embryo assay as chemosensitivity test for malignant glioma.

Authors:  K Shoin; J Yamashita; F Enkaku; T Sasaki; M Tanaka; Y Endo
Journal:  Jpn J Cancer Res       Date:  1991-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.